AskMayoExpert. Genitourinary syndrome of menopause. Mayo Clinic; 2022.
FAQs: Vulvovaginal health. American College of Obstetricians and Gynecologists. https://www.acog.org/womens-health/faqs/vulvovaginal-health. Accessed Feb. 20, 2023.
North American Menopause Society. The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause. 2020; doi:10.1097/GME.0000000000001609.
DeCherney AH, et al. Menopause and post-menopause. In: Current Diagnosis & Treatment: Obstetrics & Gynecology. 12th ed. McGraw-Hill; 2019. https://accessmedicine.mhmedical.com. Accessed Feb. 20, 2023.
Thomas HN, et al. Female sexual function at midlife and beyond. Obstetrics and Gynecology Clinics of North America. 2018;45:709.
Bachman G, et al. Genitourinary syndrome of menopause (vulvovaginal atrophy): Clinical manifestations and diagnosis. https://www.uptodate.com/contents/search. Accessed Feb. 20, 2023.
Bachmann G, et al. Genitourinary syndrome of menopause (vulvovaginal atrophy): Treatment. https://www.uptodate.com/contents/search. Accessed Feb. 21, 2023.
Biehl C, et al. A systematic review of the efficacy and safety of vaginal estrogen products for the treatment of genitourinary syndrome of menopause. Menopause. 2019; doi:10.1097/GME.0000000000001221.
Di Donato V, et al. Ospemifene for the treatment of vulvar and vaginal atrophy: A meta-analysis of randomized trials. Part I: Evaluation of efficacy. Maturitas. 2019; doi: 10.1016/j.maturitas.2018.11.016.
Di Donato V, et al. Ospemifene for the treatment of vulvar and vaginal atrophy: A meta-analysis of randomized trials. Part II: Evaluation of tolerability and safety. Maturitas. 2019; doi:10.1016/j.maturitas.2018.11.017.
North American Menopause Society. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022; doi:10.1097/GME.0000000000002028.
Menopausal symptoms in depth. National Center for Complementary and Integrative Health. https://nccih.nih.gov/health/menopause/menopausesymptoms. Accessed March 1, 2019.
Treatment of urogenital symptoms in individuals with a history of estrogen-dependent breast cancer. The American College of Obstetricians and Gynecologists. https://www.acog.org/clinical/clinical-guidance/clinical-consensus/articles/2021/12/treatment-of-urogenital-symptoms-in-individuals-with-a-history-of-estrogen-dependent-breast-cancer. Accessed Feb. 27, 2023.